Points to Consider for Sensitivity to Oxidation by Peroxide

Parenteral Drug Association , 2020

Publisher: PDA

File Format: PDF

$162.00$325.00


PDA's Points to Consider for Sensitivity to Oxidation by Peroxide addresses aspects to consider in the design, development, processing, instrumentation, materials, and equipment specific to issues with products sensitive to oxidation when exposed to H2O2. This document primarily applies to isolator systems, where vapor phase hydrogen peroxide (VPHP) or vaporized hydrogen peroxide (VHP) is used to decontaminate the system. Current issues and approaches to consider for an oxidation-sensitive product are summarized, and industry experts outline best practices for developing a manufacturing process for drug product.

General topics related to sterility assurance and development of the VHP decontamination process are not included, nor is cycle development from a sterility standpoint. General isolator considerations are addressed in PDA Points to Consider on Aseptic Processing of Sterile Pharmaceutical Products in Isolators.

More PDA Standards PDF

PEI RP100-11

PEI RP100-11

$197.00 $395.00

NZS 5823:2005A1

NZS 5823:2005A1

$134.00 $269.13

NZS 6115:2006A1

NZS 6115:2006A1

$104.00 $209.24

NZS 3604:2011

NZS 3604:2011

$118.00 $236.72